Longitudinal proteomic profiling of the inflammatory response in dengue patients

Background The immunopathogenesis of dengue virus (DENV) infection remains incompletely understood. To increase our understanding of inflammatory response in non-severe dengue, we assessed longitudinal changes in the inflammatory proteome in patients with an acute DENV infection. Methods Using a multiplex proximity extension assay (PEA), we measured relative levels of 368 inflammatory markers in plasma samples from hospitalized patients with non-severe DENV infection in the acute (n = 43) and convalescence (n = 35) phase of the infection and samples of healthy controls (n = 10). Results We identified 203 upregulated and 39 downregulated proteins in acute versus convalescent plasma samples. The upregulated proteins had a strong representation of interferon (IFN) and IFN-inducible effector proteins, cytokines (e.g. IL-10, IL-33) and cytokine receptors, chemokines, pro-apoptotic proteins (e.g. granzymes) and endothelial markers. A number of differentially expressed proteins (DEPs) have not been reported in previous studies. Functional network analysis highlighted a central role for IFNγ, IL-10, IL-33 and chemokines. We identified different novel associations between inflammatory proteins and circulating concentrations of the endothelial glycocalyx disruption surrogate marker syndecan-1. Conclusion: This unbiased proteome analysis provides a comprehensive insight in the inflammatory response in DENV infection and its association with glycocalyx disruption.

[1]  B. Alisjahbana,et al.  Effect of oseltamivir phosphate versus placebo on platelet recovery and plasma leakage in adults with dengue and thrombocytopenia; a phase 2, multicenter, double-blind, randomized trial , 2022, PLoS neglected tropical diseases.

[2]  Jixin Zhong,et al.  IL-33 in Rheumatic Diseases , 2021, Frontiers in Medicine.

[3]  M. Gershwin,et al.  Targeting the RANK/RANKL pathway in autoimmune disease and malignancy: future perspectives , 2021, Expert review of clinical immunology.

[4]  B. Alisjahbana,et al.  Comparative cytokine profiling identifies common and unique serum cytokine responses in acute chikungunya and dengue virus infection , 2021, BMC Infectious Diseases.

[5]  L. Cedillo-Barrón,et al.  Dengue Virus Induces the Expression and Release of Endocan from Endothelial Cells by an NS1–TLR4-Dependent Mechanism , 2021, Microorganisms.

[6]  Varodom Charoensawan,et al.  Innate Lymphoid Cells Activation and Transcriptomic Changes in Response to Human Dengue Infection , 2021, Frontiers in Immunology.

[7]  Y. Lo,et al.  Cytokine Signature of Dengue Patients at Different Severity of the Disease , 2021, International journal of molecular sciences.

[8]  S. Rampal,et al.  Is there any association between body mass index and severity of dengue infection? , 2021, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  B. Thorand,et al.  Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling. , 2020, Journal of proteome research.

[10]  G. Ogg,et al.  Dysfunctional Innate Immune Responses and Severe Dengue , 2020, Frontiers in Cellular and Infection Microbiology.

[11]  S. Yacoub,et al.  Visual and Biochemical Evidence of Glycocalyx Disruption in Human Dengue Infection, and Association With Plasma Leakage Severity , 2020, Frontiers in Medicine.

[12]  M. Renault,et al.  Desert Hedgehog-Driven Endothelium Integrity Is Enhanced by Gas1 (Growth Arrest-Specific 1) but Negatively Regulated by Cdon (Cell Adhesion Molecule-Related/Downregulated by Oncogenes) , 2020, Arteriosclerosis, Thrombosis and Vascular Biology.

[13]  S. Pukrittayakamee,et al.  Prevalence and clinical manifestations of dengue in older patients in Bangkok Hospital for Tropical Diseases, Thailand. , 2020, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  T. Nakashima,et al.  RANKL biology: bone metabolism, the immune system, and beyond , 2020, Inflammation and Regeneration.

[15]  Bjoern Peters,et al.  Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease , 2019, Cell reports.

[16]  H. Ye,et al.  Quantitative Comparative Proteomics Reveal Biomarkers for Dengue Disease Severity , 2019, Front. Microbiol..

[17]  J. Andersen,et al.  TRIM21—From Intracellular Immunity to Therapy , 2019, Front. Immunol..

[18]  S. Hay,et al.  The current and future global distribution and population at risk of dengue , 2019, Nature Microbiology.

[19]  K. Conzelmann,et al.  Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins. , 2019, Cell reports.

[20]  A. Sakuntabhai,et al.  Neutrophil Activation and Early Features of NET Formation Are Associated With Dengue Virus Infection in Human , 2019, Front. Immunol..

[21]  Francesco Vallania,et al.  A 20-Gene Set Predictive of Progression to Severe Dengue , 2019, Cell reports.

[22]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[23]  B. Ryffel,et al.  Interleukin‐33 contributes to disease severity in Dengue virus infection in mice , 2018, Immunology.

[24]  B. Schwikowski,et al.  A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival , 2018, The Journal of infectious diseases.

[25]  J. Todd,et al.  The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus , 2018, bioRxiv.

[26]  C. Mok,et al.  Serum Cytokine Profiles in Patients with Dengue Fever at the Acute Infection Phase , 2018, Disease markers.

[27]  Sanjeeva Srivastava,et al.  Clinical Proteomics and Cytokine Profiling for Dengue Fever Disease Severity Biomarkers. , 2017, Omics : a journal of integrative biology.

[28]  C. Münz,et al.  The neuropeptide galanin modulates natural killer cell function , 2017, Neuropeptides.

[29]  R. T. Sasmono,et al.  Association of Endothelial Glycocalyx and Tight and Adherens Junctions With Severity of Plasma Leakage in Dengue Infection , 2017, The Journal of infectious diseases.

[30]  L. Rénia,et al.  Severity of Plasma Leakage Is Associated With High Levels of Interferon &ggr;–Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection , 2017, The Journal of infectious diseases.

[31]  E. Harris,et al.  Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability , 2016, PLoS pathogens.

[32]  I. Sayers,et al.  The challenge of measuring IL‐33 in serum using commercial ELISA: lessons from asthma , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[33]  G. Zeng,et al.  Suppressed expression of miR-378 targeting gzmb in NK cells is required to control dengue virus infection , 2015, Cellular and Molecular Immunology.

[34]  S. Halstead,et al.  Dengue infection , 2016, Nature Reviews Disease Primers.

[35]  Maarten A. Bijl,et al.  Time since Onset of Disease and Individual Clinical Markers Associate with Transcriptional Changes in Uncomplicated Dengue , 2015, PLoS neglected tropical diseases.

[36]  A. Gutiérrez-Escolano,et al.  Let-7c overexpression inhibits dengue virus replication in human hepatoma Huh-7 cells. , 2015, Virus research.

[37]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[38]  M. Caulfield,et al.  Endothelial C-type natriuretic peptide maintains vascular homeostasis. , 2014, The Journal of clinical investigation.

[39]  B. Engelhardt,et al.  The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions , 2014, Cell and Tissue Research.

[40]  M. Colonna,et al.  Activator of Adaptive Responses Modulator of Early Cytokine Responses and Dual Function of Cd70 in Viral Infection: Dual Function of Cd70 in Viral Infection: Modulator of Early Cytokine Responses and Activator of Adaptive Responses , 2022 .

[41]  Gathsaurie Neelika Malavige,et al.  Serum IL-10 as a marker of severe dengue infection , 2013, BMC Infectious Diseases.

[42]  Zhining Wang,et al.  Sequential Waves of Gene Expression in Patients with Clinically Defined Dengue Illnesses Reveal Subtle Disease Phases and Predict Disease Severity , 2013, PLoS neglected tropical diseases.

[43]  A. F. Arrieta,et al.  High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue. , 2013, Cytokine.

[44]  P. D. de Groot,et al.  Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13 , 2012, PLoS neglected tropical diseases.

[45]  Cameron P. Simmons,et al.  Current concepts: Dengue , 2012 .

[46]  B. Ryffel,et al.  IFN-γ Production Depends on IL-12 and IL-18 Combined Action and Mediates Host Resistance to Dengue Virus Infection in a Nitric Oxide-Dependent Manner , 2011, PLoS neglected tropical diseases.

[47]  Mark J. Schreiber,et al.  Characterization of early host responses in adults with dengue disease , 2011, BMC infectious diseases.

[48]  Martin Lundberg,et al.  Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood , 2011, Nucleic acids research.

[49]  L. Ganju,et al.  Dengue virus infection activates cellular chaperone Hsp70 in THP-1 cells: downregulation of Hsp70 by siRNA revealed decreased viral replication. , 2010, Viral immunology.

[50]  R. Sanderson,et al.  Heparanase Plays a Dual Role in Driving Hepatocyte Growth Factor (HGF) Signaling by Enhancing HGF Expression and Activity*♦ , 2010, The Journal of Biological Chemistry.

[51]  L. James,et al.  Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) , 2010, Proceedings of the National Academy of Sciences.

[52]  Niall J. Lennon,et al.  The Early Whole-Blood Transcriptional Signature of Dengue Virus and Features Associated with Progression to Dengue Shock Syndrome in Vietnamese Children and Young Adults , 2010, Journal of Virology.

[53]  R. Higgs,et al.  Self Protection from Anti-Viral Responses – Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors , 2010, PloS one.

[54]  P. Buchy,et al.  Genome-Wide Expression Profiling Deciphers Host Responses Altered during Dengue Shock Syndrome and Reveals the Role of Innate Immunity in Severe Dengue , 2010, PloS one.

[55]  M. Little,et al.  Loss of renal microvascular integrity in postnatal Crim1 hypomorphic transgenic mice. , 2009, Kidney international.

[56]  Eunkyung Kim,et al.  Cytosolic Aminopeptidases Influence MHC Class I-Mediated Antigen Presentation in an Allele-Dependent Manner1 , 2009, The Journal of Immunology.

[57]  Ulisses Braga-Neto,et al.  Gene Expression Profiling during Early Acute Febrile Stage of Dengue Infection Can Predict the Disease Outcome , 2009, PloS one.

[58]  N. M. Dung,et al.  Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection. , 2009, The Journal of infectious diseases.

[59]  Jeerayut Chaijaruwanich,et al.  Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. , 2008, The Journal of infectious diseases.

[60]  Pieter H. Reitsma,et al.  Differential Gene Expression Changes in Children with Severe Dengue Virus Infections , 2008, PLoS neglected tropical diseases.

[61]  Joshy George,et al.  Host Gene Expression Profiling of Dengue Virus Infection in Cell Lines and Patients , 2007, PLoS neglected tropical diseases.

[62]  M. Little,et al.  Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development. , 2007, Journal of the American Society of Nephrology : JASN.

[63]  J. Farrar,et al.  Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. , 2007, The Journal of infectious diseases.

[64]  A. Theamboonlers,et al.  An evidence of intestinal mucosal injury in dengue infection. , 2006, The Southeast Asian journal of tropical medicine and public health.

[65]  A. Mantovani,et al.  Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections , 2005, Journal of medical virology.

[66]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[67]  G. Korbutt,et al.  Granzyme B: a natural born killer , 2003, Immunological reviews.

[68]  M. V. van Oers,et al.  Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. , 2002, Blood.

[69]  J. Ezaki,et al.  Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase. , 2000, Journal of biochemistry.

[70]  C. Hack,et al.  Extracellular granzyme A, complexed to proteoglycans, is protected against inactivation by protease inhibitors. , 2000, Blood.

[71]  A. Nisalak,et al.  Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity , 1999, Journal of medical virology.

[72]  T. Ley,et al.  Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Banchereau,et al.  A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. , 1998, Immunity.

[74]  C. Hack,et al.  Expression of Human Recombinant Granzyme A Zymogen and Its Activation by the Cysteine Proteinase Cathepsin C (*) , 1996, The Journal of Biological Chemistry.

[75]  J. Garland.  The New England Journal of Medicine. , 1961, Canadian Medical Association journal.